The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE phase 3 clinical trial published today in the New England Journal of Medicine ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

Nearly two in three people with fatty liver disease lost some of the liver fat and inflammation after using semaglutide 2.4 ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...